Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
AlloVir ( (ALVR) ) has issued an update.
AlloVir, Inc. announced that Dr. Diana Brainard has stepped down as Chief Executive Officer and director, with Vikas Sinha taking over as CEO effective December 19, 2024. Sinha, who has extensive experience in executive finance roles within the life sciences industry, is expected to lead the company following the departure of Dr. Brainard, who left with a comprehensive severance package.
More about AlloVir
YTD Price Performance: -33.82%
Average Trading Volume: 341,058
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $51.12M
See more data about ALVR stock on TipRanks’ Stock Analysis page.
